Editor’s Note: The following guest post is published with the permission of its author, Edward J. Schloss, MD, (Twitter ID @EJSMD) the medical director of cardiac electrophysiology at Christ Hospital ...
February 20, 2012 (Rochester, Minnesota) — Crossing a bioprosthetic tricuspid valve with an implantable cardioverter defibrillator (ICD) or pacemaker lead does not appear to increase the risk of ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
SAN FRANCISCO — An implantable cardioverter defibrillator (ICD) with a lead system that inserts just below the sternum performed promisingly in a recent early experience that sets the stage for a more ...
In recent years defects in ICD leads have caused recalls and provoked broad concerns among health care professionals and patients alike about the safety and reliability of ICDs and other implanted ...
Please provide your email address to receive an email when new articles are posted on . BOSTON — The risk for complications from implantable cardioverter defibrillator lead revisions and extractions ...
Please provide your email address to receive an email when new articles are posted on . A planned expansion of the National Implantable Cardioverter Defibrillator Registry, currently accruing data on ...
The randomized multicenter ATLAS trial of more than 500 persons has found that subcutaneous implantable cardioverter defibrillators (S-ICDs) reduce perioperative, lead-related complications without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results